Thesis
NVO is attempting a structural reversal after a deep corrective phase, supported by both long-term trend support and improving fundamental visibility.
Context
- Weekly timeframe
- 70% correction from cycle highs
- Price has respected the long-term trendline originating in 2016
- Recent product developments in weight-loss therapies improve long-term business outlook
What I see
- Price held the long-term rising support after the correction
- Recent advance reclaimed the 50-day moving average
- Price is consolidating above short-term support, suggesting stabilization
- Structure is transitioning from decline to base formation
What matters now
- Holding above the 50-day MA keeps the early reversal structure intact
- Next key test sits at the confluence of the 0.618 Fibonacci retracement and the 200-day moving average near the $60 area
Buy / Accumulation zone
- Pullbacks toward the current base and rising support zone remain the area of interest
Targets
- Initial resistance at the 0.618 Fib / 200-day MA confluence
- A confirmed higher low after that test would define Wave 1–2 structure
- Longer-term reference remains the 200-week moving average overhead
Risk / Invalidation
- Loss of the long-term trendline would invalidate the reversal thesis
NVO is attempting a structural reversal after a deep corrective phase, supported by both long-term trend support and improving fundamental visibility.
Context
- Weekly timeframe
- 70% correction from cycle highs
- Price has respected the long-term trendline originating in 2016
- Recent product developments in weight-loss therapies improve long-term business outlook
What I see
- Price held the long-term rising support after the correction
- Recent advance reclaimed the 50-day moving average
- Price is consolidating above short-term support, suggesting stabilization
- Structure is transitioning from decline to base formation
What matters now
- Holding above the 50-day MA keeps the early reversal structure intact
- Next key test sits at the confluence of the 0.618 Fibonacci retracement and the 200-day moving average near the $60 area
Buy / Accumulation zone
- Pullbacks toward the current base and rising support zone remain the area of interest
Targets
- Initial resistance at the 0.618 Fib / 200-day MA confluence
- A confirmed higher low after that test would define Wave 1–2 structure
- Longer-term reference remains the 200-week moving average overhead
Risk / Invalidation
- Loss of the long-term trendline would invalidate the reversal thesis
Long term investor. Open portfolio and full thesis on eToro: etoro.com/people/maratteo
Отказ от ответственности
Информация и публикации не предназначены для предоставления и не являются финансовыми, инвестиционными, торговыми или другими видами советов или рекомендаций, предоставленных или одобренных TradingView. Подробнее читайте в Условиях использования.
Long term investor. Open portfolio and full thesis on eToro: etoro.com/people/maratteo
Отказ от ответственности
Информация и публикации не предназначены для предоставления и не являются финансовыми, инвестиционными, торговыми или другими видами советов или рекомендаций, предоставленных или одобренных TradingView. Подробнее читайте в Условиях использования.